Comparison of rhythm and rate control medications for new-onset atrial fibrillation in septic patients: MIMIC-IV database analysis
database[Title] 2025-05-14
Summary:
CONCLUSIONS: In septic patients with NOAF, rhythm control and rate control medications showed no difference in 28-day, ICU, or 1-year mortality.However, rhythm control may provide transient hemodynamic stabilization through rapid cardioversion, potentially beneficial during acute critical illness.